國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 925176      線上人數 : 892
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    期刊論文 [32/32]

    類別統計

    近3年內發表的文件:7(87.50%)
    含全文筆數:8(100.00%)

    文件下載次數統計
    下載大於0次:8(100.00%)
    下載大於100次:6(75.00%)
    檔案下載總次數:922(14.00%)

    最後更新時間: 2024-12-01 09:15


    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-8 / 8. (共1頁)
    1 
    每頁顯示[10|25|50]項目

    日期題名關聯
    2023-11 Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome Annals of Oncology. 2023 Nov;34(Suppl. 3):S1390.
    2023-11 Single-cell RNA sequencing via Endoscopic Ultrasoundguided Fine-Needle Biopsy (EUS-FNB) Pancreatic Biopsies uncovered an aggressive subclone with a poor prognosis Annals of Oncology. 2023 Nov;34(Suppl. 4):S1536-S1537.
    2023-06 Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS) Journal of Clinical Oncology. 2023 Jun;41(16 Suppl.):Meeting Abstract 11551.
    2022-10 Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression Hepatology. 2022 Oct;76(Suppl.1):S1411-S1412.
    2022-07 Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors Annals of Oncology. 2022 Jul;33(Suppl. 6):S484.
    2022-07 Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
    2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
    2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.

    顯示項目1-8 / 8. (共1頁)
    1 
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋